TABLE 5.
Targeted gene(s) | Effect of null mutation on viability | Tissue affected | Other defects |
---|---|---|---|
Lmo1 | None | None detectable | |
Lmo2 | Death at E9.5 | Failure of primitive erythropoiesis | Failure of adult hematopoiesis, failure of angiogenesis (assessed in chimeras) |
Lmo3 | None | None detectable | |
Lmo1 + Lmo3 | Immediate postnatal death | Unspecified central nervous system abnormalities | |
Lmo4 | Perinatal death | Neural tube closure defect |